London, UK, 31st March 2020 / Sciad Newswire / Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, launch
Healthcare
Tue, 31/03/2020 - 08:00
Mon, 30/03/2020 - 07:30
London, UK, 30th March 2020 / Sciad Newswire / The UK Innovation and Science Seed Fund (UKI2S) has publis
Thu, 23/01/2020 - 07:00
Proposals feature a soft robotic heart, a cure for genetic heart disease, a heart attack vaccine and next generation health tech
Wed, 09/10/2019 - 07:00
Belfast, UK, 9th October 2019 / Sciad Newswire / Examen, a world leader in male fertility testing, is please
Thu, 19/09/2019 - 07:00
Independent analysis reveals more illegal and unsafe products on the market
Tue, 17/09/2019 - 07:00
Stevenage, UK, 17th September 2019 / Sciad Newswire / Procarta Biosystems, a privately held UK-based b
Sat, 25/05/2019 - 06:30
Potential New Treatment for Acute Heart Failure Presented at the Heart Failure 2019 Congress
TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system
Thu, 23/05/2019 - 07:00
The completion of series B fundraise of £10.3 million
The appointment of Paul Atherton as Chairman
COMPLETION OF SERIES B FUNDRAISE
Tue, 21/05/2019 - 15:15
Coventry, UK, 21st May 2019 / Sciad Newswire / Medherant Limited (“Medherant”), the clinical-stage developer of innovat
Tue, 21/05/2019 - 07:00
London, UK, 21st May 2019 / Sciad Newswire / The £27m UK Innovation & Science Seed Fund (UKI2S) and In